NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
May 30, 2006 • Volume 3 / Number 22 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
New Studies Highlight the Value and Timing of Colonoscopy

Director's Update
Continuing the Legacy of a Great Leader

Spotlight
After Gleevec, Targeted Drugs Acquire More Targets

Cancer Research Highlights
RNA Interference Technique Causes Toxicity in Mice

Cryoablation for Small Renal Tumors Shows Promising Results

MRI Screening Is Cost Effective for Some BRCA Carriers

Transfusions During Surgery Linked to Cancer-Related Mortality

World No Tobacco Day Observed

Funding Opportunities

Featured Clinical Trial
Flavopiridol for Previously Treated Chronic Lymphocytic Leukemia

Notes
Joint Research Fellowships in Cancer Available

Coffee, Tea, & Chats at Mark O. Hatfield Clinical Research Center

IARC Welcomes India and Korea

Cancer Center Profile
UC Davis Cancer Center

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Featured Article

New Studies Highlight the Value and Timing of Colonoscopy

Two studies of colonoscopy screening reported in the May 24 and 31 Journal of the American Medical Association (JAMA) fortified evidence of the test's value, and "address two very important and unresolved questions," according to an accompanying editorial.

Is 10 years the right amount of time to wait for a second colonoscopy after a negative initial colonoscopy exam? Absolutely, according to researchers at the University of Manitoba in Winnipeg, Canada, who conducted a retrospective population-based analysis using a cohort of 35,975 patients screened over a period of 15 years from 1989 to 2003.

The second question is whether people 80 years of age and older will increase their life expectancy by colonoscopy screening.  Read more  

Director's Update

Guest Update by Dr. Mark B. Clanton

Continuing the Legacy of a Great Leader

Last week, the world lost one of its most important public health leaders, Dr. Lee Jong-Wook, the Director-General of the World Health Organization (WHO). It's not often that the passing of a single individual is mourned by people worldwide, but in the case of Dr. Lee, it's absolutely true.

And that's because his work touched so many. Dr. Lee dedicated his life to improving the health of children and adults on every continent - orchestrating programs that have had a substantial impact on reducing the rates of diseases such as tuberculosis and polio, and have led to the proliferation of new and better vaccines to protect children from preventable but often deadly diseases.  Read more  

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov